Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Fisetin to Reduce Senescence and Mobility Impairment in Peripheral Artery Disease: the FIRST Pilot Randomized Trial

NCT06399809 is registered in ClinicalTrials.gov with Northwestern University as lead sponsor.

NCT NCT06399809
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06399809 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Fisetin to Reduce Senescence and Mobility Impairment in Peripheral Artery Disease: the FIRST Pilot Randomized Trial
Lead sponsor
Northwestern University
Phase
Phase 2
Overall status
Recruiting
Start date
September 30, 2024
Completion date
June 30, 2027
Enrollment
34 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

aging, claudication, peripheral arterial disease, peripheral vascular diseases, walking, difficulty